Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer

Anders Olin1, Claes N Ladefoged1, Natasha H Langer1

  • 1Department of Clinical Physiology, Nuclear Medicine, and PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; and.

Insights

Artifacts in thoracic MR-AC maps frequently impact PET/MRI scans, affecting quantitative 18F-FDG PET measurements in non-small cell lung cancer patients. Careful visual inspection of MR-AC maps is crucial for reliable SUV quantification in serial studies.

Area of Science:

  • Medical Imaging
  • Nuclear Medicine
  • Radiology

Background:

  • Quantitative PET/MRI relies on accurate MR-based attenuation correction (MR-AC).
  • Thoracic MR-AC quality is critical for reliable 18F-FDG PET quantification in lung cancer patients.

Purpose of the Study:

  • To evaluate the quality of vendor-provided thoracic MR-AC maps.
  • To assess the reproducibility of MR-AC's impact on 18F-FDG PET quantification in non-small cell lung cancer (NSCLC) patients.

Main Methods:

  • Eleven NSCLC patients underwent multiple thoracic PET/MRI scan-rescan examinations.
  • Two PET images were reconstructed using different intrasubject MR-AC maps.
  • Ninety MR-AC maps were visually assessed for artifacts; tumor SUVs were quantified and compared.

Main Results:

  • Artifacts were observed in 86% of MR-AC maps, with 30% potentially affecting tumor SUV.
  • SUVmean and SUVmax showed coefficients of variation of 5.6% and 6.6%, respectively.
  • Scan-rescan SUV variations were within ±20% in 95% of cases, with motion-affected scans showing greater variability.

Conclusions:

  • Frequent artifacts in thoracic MR-AC maps compromise PET/MRI reproducibility.
  • Inconsistent SUV measurements due to MR-AC artifacts may affect therapy response assessment.
  • Visual inspection of MR-AC maps is essential for reliable SUV quantification in serial PET/MRI studies.

Related Concept Videos